GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $18,000 | +12.5% | 458 | +17.1% | 0.01% | 0.0% |
Q1 2019 | $16,000 | -84.8% | 391 | -85.7% | 0.01% | -87.2% |
Q4 2018 | $105,000 | -20.5% | 2,740 | -16.7% | 0.05% | +9.3% |
Q3 2018 | $132,000 | +3.1% | 3,291 | +3.3% | 0.04% | -18.9% |
Q2 2018 | $128,000 | +23.1% | 3,186 | +20.1% | 0.05% | +71.0% |
Q1 2018 | $104,000 | +300.0% | 2,652 | +258.4% | 0.03% | +287.5% |
Q4 2017 | $26,000 | -69.8% | 740 | -65.3% | 0.01% | -77.1% |
Q3 2017 | $86,000 | -36.3% | 2,130 | -35.5% | 0.04% | -37.5% |
Q2 2017 | $135,000 | +10.7% | 3,301 | +16.1% | 0.06% | +5.7% |
Q1 2017 | $122,000 | +269.7% | 2,844 | +233.0% | 0.05% | +278.6% |
Q4 2016 | $33,000 | -38.9% | 854 | -31.5% | 0.01% | -54.8% |
Q3 2016 | $54,000 | +1.9% | 1,246 | +5.6% | 0.03% | -6.1% |
Q2 2016 | $53,000 | +71.0% | 1,180 | +55.5% | 0.03% | +26.9% |
Q1 2016 | $31,000 | +63.2% | 759 | +59.1% | 0.03% | +36.8% |
Q4 2015 | $19,000 | – | 477 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |